This inventor holds 1 USPTO granted patent. Top assignee: Biovitrum Ab. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Cecilia Nilsson: Innovator in Steroid Dehydrogenase Inhibitors
Introduction
Cecilia Nilsson is a prominent inventor based in Solna, Sweden. She has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for steroid dehydrogenases. Her work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Cecilia holds 1 patent related to her research. The patent is titled "Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1." This invention pertains to compounds that can effectively inhibit the enzyme, which plays a vital role in steroid metabolism.
Career Highlights
Cecilia is associated with Biovitrum AB, a company known for its innovative approaches in biotechnology. Her role at the company has allowed her to focus on groundbreaking research that has the potential to impact the pharmaceutical industry significantly.
Collaborations
Cecilia has collaborated with notable colleagues, including Meredith Williams and Catrine Dreifeldt. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Cecilia Nilsson's contributions to the field of steroid dehydrogenase inhibitors exemplify her dedication to innovation in biochemistry. Her work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile